SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: AHM who wrote (749)7/2/1998 12:44:00 PM
From: Robert Knight  Read Replies (1) | Respond to of 1510
 
>>Perhaps you might like to detail how a market maker trader can "lean" on a stock
without losing money except by going short - which has not happened with shares of
IMNR to any material degree over the past 4 trading sessions. <<

Is there not a documented 1.7 million short position in the stock? I say documented because shorts utilize the "no report" rule by also trading through Canada (a total MANIPULATIVE farce BTW). To protect a position and to potentially get out, the short group works on offering stock at the ask while hitting weak bids. The desired effect is to induce selling (fear/margin calls) and break sentiment.

I have watched this stock trade all week. I am an adept enough trader to know when a short is working a stock. Yes I have acknowledged that there could be some legitimate selling, but the short is also utilizing this opportunity to "lean" on the stock and keep momentum in a negative direction. They have a vested interest to do so in light of the conference no?

I posted the link to another trader from yahoo who has been watching and seeing the exact same things I have pointed out. This is not a simple supply/demand equation. If you think the MM's play by the rules I have some nice property for you in S. Fla....

Robert